---
schema_version: "secwatch.filing_event.v1"
accession: "0001818331-23-000060"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T02:35:55.319934+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GeneDx Q2 2023: Exome/genome revenue up 36% YoY; cash burn down 36%

## Summary
- Continuing ops revenue $45.2M (+13% YoY); exome/genome rev. $28.7M (+36% YoY).
- Exome/genome volume 11,900 tests (+56% YoY); total tests ~55,000.
- Adj. gross margin 37% (pro forma), up from 34% in Q1; total adj. gross margin 42%.
- Adj. net loss $41.8M, improved 37% YoY; cash burn $53M, improved 36% YoY.
- FY2023 revenue guidance reaffirmed $205-220M; H2 cash use $70-85M; profitability target 2025.

## SEC filing metadata
- accession: 0001818331-23-000060
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000060/0001818331-23-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000060/smfr-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818331-23-000060
- JSON: https://secwatch.observer/filing/0001818331-23-000060.json
- Plain text: https://secwatch.observer/filing/0001818331-23-000060.txt

## Key facts
- Earnings Releases
  GeneDx Holdings Corp. reported the second quarter of 2023 results: revenue $48.7 million, net income $46.7 million. Guidance reaffirmed.
  - Period: the second quarter of 2023
  - Revenue: $48.7 million
  - Net income: $46.7 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: net loss for the second quarter of 2023 was $41.8 million 2 , an improvement of 37% year-over-year and 17% sequentially. · Revenue 1 : Revenue for the second quarter of 2023 was $48.7 million, compared to $36.2 million in the second quarter of 2022. · Gross Margin 1 : Gross margin for the second quarter of 2023 was 39%. Adjusted gross margin for the second quarter of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000060/0001818331-23-000060-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.